Selleri C, Maciejewski J P, De Rosa G, Raiola A, Risitano A M, Picardi M, Pezzullo L, Luciano L, Ricci P, Varriale G, Della Cioppa P, Del Vecchio L, Rotoli B
Division of Hematology, Federico II University School of Medicine, Naples, Italy.
Bone Marrow Transplant. 1999 May;23(10):1029-37. doi: 10.1038/sj.bmt.1701759.
We investigated bone marrow (BM) and circulating (PB) hematopoietic progenitor cells in 37 normal donors and in 25 patients 1 to 8 years after successful allogeneic bone marrow transplant. At the time of testing, transplanted patients had normal blood counts and bone marrow cellularity. By flow cytometry, BM CD34+ cells were found to be three- to four-fold decreased in transplanted patients compared to normal donors, while the number of PB CD34+ cells was the same as in normal donors. Using a methylcellulose colony assay, primary BM colony-forming cells (CFU-GM) were decreased 2.1-fold, whereas PB CFU-GM were only marginally decreased. In a long-term culture initiating cell (LTC-IC) assay, an eight-fold decrease of early progenitor cells was observed in the marrow of transplanted patients compared to normal donors, and a five-fold decrease was documented in peripheral blood. We found that the BM LTC-IC cell number correlated with concurrently determined BM CD34+ cells and committed progenitor cell number (measured as CFU-GM) and with PB LTC-IC number, but not with PB CFU-GM and CD34+ cells. We conclude that marrow and circulating early stem cell compartments, as measured by the LTC-IC assay, are greatly and permanently depressed following bone marrow transplant. The correlation between BM and PB LTC-IC indicates that the enumeration of circulating LTC-IC can be used as a measure of the stem cell compartment in the bone marrow after transplant. It seems that the deficiency of the most immature progenitor cells persists forever after successful bone marrow transplant; this means that a complete hematopoietic reconstitution can be sustained by a reduced stem cell pool.
我们对37名正常供者以及25名异基因骨髓移植成功后1至8年的患者的骨髓(BM)和循环(PB)造血祖细胞进行了研究。在检测时,移植患者的血细胞计数和骨髓细胞成分均正常。通过流式细胞术发现,与正常供者相比,移植患者的骨髓CD34+细胞减少了三至四倍,而外周血CD34+细胞数量与正常供者相同。使用甲基纤维素集落测定法,原发性骨髓集落形成细胞(CFU-GM)减少了2.1倍,而外周血CFU-GM仅略有减少。在长期培养起始细胞(LTC-IC)测定中,与正常供者相比,移植患者骨髓中的早期祖细胞减少了八倍,外周血中减少了五倍。我们发现,骨髓LTC-IC细胞数量与同时测定的骨髓CD34+细胞和定向祖细胞数量(以CFU-GM衡量)以及外周血LTC-IC数量相关,但与外周血CFU-GM和CD34+细胞无关。我们得出结论,通过LTC-IC测定法测量,骨髓移植后骨髓和循环早期干细胞成分受到极大且永久性的抑制。骨髓和外周血LTC-IC之间的相关性表明,循环LTC-IC的计数可作为移植后骨髓中干细胞成分的一种衡量指标。似乎在成功的骨髓移植后,最不成熟祖细胞的缺乏会永远持续;这意味着减少的干细胞池可以维持完全的造血重建。